ARIH2 serves as a potential prognostic biomarker for hepatocellular carcinoma associated with immune infiltration and ferroptosis
The expression level of ARIH2 may serve as a promising biomarker for the diagnosis and prognosis of HCC, as well as a potential drug target, which holds great significance for the development of targeted therapy for HCC.
Authors
- Bo Li (ORCID: https://orcid.org/0000-0002-8617-900X)
- Xiaoli Yang (ORCID: https://orcid.org/0000-0002-7172-5995)
- Qiang Shu (ORCID: https://orcid.org/0000-0001-5757-1443)
- Qiang Wang (ORCID: https://orcid.org/0009-0004-4325-6281)
Institutions
- Affiliated Hospital of Southwest Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.3389/fimmu.2025.1548691
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Affiliated Hospital of Southwest Medical University